🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Basal Cell Carcinoma of Skin

Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma NCT07381972Phase 31 site📍 Jaú University of Sao Paulo · Tests: Control Arm (Conventional Therapy), Experimental arm Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice NCT07501780n/a1 site📍 Maastricht Maastricht University Medical Center AI-Based Risk Classification and Histopathological Subtype Prediction of Basal Cell Carcinoma Using Dermoscopic Images NCT07677124n/a1 site📍 Istanbul Istanbul Training and Research Hospital Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors NCT07628634EARLY Phase 11 site📍 Orange University of California, Irvine · Tests: Methionine-Reduced Diet Skin Cancer and Hyperthermia and Radiotherapy NCT06384053NA4 sites📍 Aarau📍 Winterthur📍 Bern Kantonsspital Winterthur KSW · Tests: Water-filtered infrared-A-hyperthermia (wIRA) hyperthermia combined, Radiotherapy (RT) Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma NCT07251413Phase 1, Phase 24 sites📍 Barcelona📍 Barcelona📍 Madrid Instituto Oncológico Dr Rosell · Tests: cemiplimab, Topical imiquimod Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies NCT07682831NA1 site📍 Victor University of Rochester · Tests: Two photon microscopy imaging A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors NCT07600476Phase 13 sites📍 Munich📍 Würzburg📍 Münster Kupando GmbH · Tests: KUP-101A Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma NCT03521830Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Nivolumab, Ipilimumab, Relatlimab Multimodal Imaging of Basal Cell Carcinoma: A Usability Study NCT07803406n/a1 site📍 Copenhagen Bispebjerg Hospital · Tests: Non-invasive multimodal skin imaging Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling NCT06330350n/a1 site📍 Maastricht Maastricht University Medical Center · Tests: Qualitative interview Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer NCT05896839Phase 1, Phase 226 sites📍 La Jolla📍 Los Angeles📍 Los Angeles National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Kidney Biopsy R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors NCT06398418Phase 12 sites📍 Denver📍 Nashville Rise Therapeutics LLC · Tests: R-5780 Familial Investigations of Childhood Cancer Predisposition NCT03050268n/a1 site📍 Memphis St. Jude Children's Research Hospital Basal Cell Carcinoma Chemoprevention Trial NCT05212246Phase 38 sites📍 Long Beach📍 San Diego📍 Bay Pines VA Office of Research and Development · Tests: 5% Imiquimod cream, Placebo Vehicle Control Cream L19IL2/TNF in Patients With Basal Cell Carcinoma NCT07227870Phase 218 sites📍 Tampa📍 Atlanta📍 New York Philogen S.p.A. · Tests: L19IL2/L19TNF Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma NCT06624475Phase 23 sites📍 Irvine📍 La Jolla📍 San Francisco University of California, San Diego · Tests: Nivolumab, Relatlimab plus Nivolumab L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) NCT07227350Phase 218 sites📍 Tampa📍 Atlanta📍 Durham Philogen S.p.A. · Tests: L19IL2, L19TNF, L19IL2/L19TNF 5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer NCT05381597Phase 2, Phase 31 site📍 Boston Boston University · Tests: Combination cream of 5-fluorouracil and calcipotriene, 5-fluorouracil cream Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study NCT07215988n/a1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Non-Interventional Study Two-photon Fluorescence Microscopy of Dermatologic Biopsies NCT07773688NA1 site📍 Victor University of Rochester · Tests: Two photon microscopy imaging Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants NCT00898638n/a4 sites📍 Nashville📍 Nashville📍 Nashville Vanderbilt University Medical Center · Tests: biologic sample preservation procedure, medical chart review Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients NCT06981325Phase 27 sites📍 Erfurt📍 Erlangen📍 Heidelberg Institut für Klinische Krebsforschung IKF GmbH at Krankenha… · Tests: Cemiplimab Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy NCT06473103NA1 site📍 Victor University of Rochester · Tests: Two photon fluorescence microscopy imaging French National Database of Rare Dermatological Cancers NCT03210935n/a34 sites📍 Dijon📍 Le Mans📍 Pierre-Bénite University Hospital, Lille Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma NCT06112522Phase 21 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Tirbanibulin Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma NCT06600165n/a1 site📍 Munich LMU Klinikum · Tests: Ex vivo confocal microscopy Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma NCT05561634Phase 21 site📍 Lille University Hospital, Lille · Tests: Radiotherapy, Observation, Vismodegib A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma NCT05157763Phase 1, Phase 23 sites📍 Aventura📍 Brandon📍 Webster MediWound Ltd · Tests: EscharEx 5% (EX-02 formulation) Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment NCT07010692Phase 1, Phase 21 site📍 New York Bruce Robinson, MD · Tests: Tirbanibulin ointment 1%, non-ablative fractional laser
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy